FutureCeuticals: vitAlign® Boosts Cellular Health & Immunity

A new study published in the International Journal of Molecular Sciences  shows that vitAlign®, a proprietary and comprehensive healthy aging innovation from FutureCeuticals, offers significant benefits in restoring cellular health and promoting a healthy immune response.

The study highlights vitAlign's effectiveness in regulating cellular function and metabolic imbalances associated with immune stressors – from seasonal colds and flu to more complex environmental and immune-related issues.

Researchers evaluated the impact of a low 50 mg dose of vitAlign in medically stable adults aged 40 to 55 years recovering from a moderate episode of COVID-19, as defined by CDC guidelines. The study compared vitAlign to a 1,000 mg dose of vitamin C, focusing on key markers and processes that directly impact immune and cellular health.

The results showed that vitAlign significantly reduced the excessive production of reactive oxygen species (ROS) in mitochondria and through the NOX2 and iNOS pathways, key mechanisms that influence immune and cellular functions. Additionally, the researchers observed an increase in circulating bioavailable nitric oxide levels, suggesting support for endothelial function and cardiovascular health. The authors noted that the increase in nitric oxide was likely attributable to vitAlign's ability to regulate multiple ROS production pathways.

In particular, vitAlign produced measurable effects within 30 minutes, which lasted up to three hours. In contrast, vitamin C, which was used as a positive control, was administered at a dose twenty times higher and did not demonstrate comparable broad-spectrum activity.

“These results build on more than 10 years of published clinical research establishing vitAlign as a significant innovation in cellular health, now directly extending to immune function,” said J. Randal Wexler, Chief Legal Officer and Vice President of R&D at FutureCeuticals. “Previously, we have shown that vitAlign improves cellular energy efficiency and helps restore metabolic balance, both acutely and over time.”

“These new results, which compare favorably with those of a well-known antioxidant like vitamin C, reinforce vitAlign’s potential as a multifaceted phytonutrient formula, providing broad support for healthy aging, cardiovascular health, and immune function,” added Wexler. “Our partners are excited about what this means for product innovation and for their customers seeking daily support for cellular health.”

About FutureCeuticals:  
FutureCeuticals, Inc. is the developer of vitAlign and a leader in the research, development, and manufacturing of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!